September 10, 2024

Post A MaxImmun paper on the identification (1) copy
September 10, 2024

Identification of human host factors required for beta-defensin-2 expression in intestinal epithelial cells upon a bacterial challenge

 A MaxImmun paper on the identification of human host factors required for beta-defensin-2 expression in intestinal epithelial cells upon a...

Post Thank you to all the European (2) copy
September 10, 2024

Our European partners !

Thank you to all the European partners of the MaxImmun consortium for their participation to the kick-off meeting at Institut...

MaxImmun is a Horizon Europe project supported by the European Union, through the European Innovation Council
Grant agreement N°101129622
Start date : January 1, 2024
Duration : 48 months

Our newsletter

An innovative therapeutic strategy to fight bacterial antibioresistance. Stay updated with the latest breakthroughs by joining our newsletter.